Piper Sandler analyst Yasmeen Rahimi downgraded Korro Bio (KRRO) to Neutral from Overweight with a price target of $11, down from $180.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio downgraded to Neutral from Buy at H.C. Wainwright
- Korro Bio downgraded to Sector Perform from Outperform at RBC Capital
- Korro Bio downgraded to Market Perform from Outperform at William Blair
- Korro Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
- Korro Bio downgraded to Market Perform from Strong Buy at Raymond James